Find Research Outputs

Search concepts
Selected Filters

Publication Year

  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

Author

  • Ayalew Tefferi
2016

Cytogenetic and molecular abnormalities in chronic myelomonocytic leukemia

Patnaik, M. M. & Tefferi, A., Feb 5 2016, In : Blood Cancer Journal. 6, e393.

Research output: Contribution to journalArticle

45 Scopus citations
2018

Chronic neutrophilic leukemia: 2018 update on diagnosis, molecular genetics and management

Elliott, M. A. & Tefferi, A., Apr 1 2018, In : American Journal of Hematology. 93, 4, p. 578-587 10 p.

Research output: Contribution to journalArticle

8 Scopus citations
2017

Diagnostic impact of the 2016 revised who criteria for polycythemia vera

Barbui, T., Thiele, J., Gisslinger, H., Carobbio, A., Vannucchi, A. M. & Tefferi, A., May 1 2017, In : American journal of hematology. 92, 5, p. 417-419 3 p.

Research output: Contribution to journalComment/debate

10 Scopus citations

Revisiting the need for bone marrow examination in chronic myeloid leukemia

Tefferi, A., Hanson, C. A. & Ketterling, R. P., 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

1 Scopus citations
2018

Atypical Phenotype and Treatment Response Pattern in a Patient with FIP1L1-PDGFRα Mutation

Bikhchandani, M., Johnson, R., Tuan, B. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : Acta Haematologica. p. 67-70 4 p.

Research output: Contribution to journalArticle

2019

Comments on pre-fibrotic myelofibrosis and how should it be managed

Barbui, T., Thiele, J., Gisslinger, H., Orazi, A., Vannucchi, A. M., Gianelli, U., Beham-Schmid, C. & Tefferi, A., Jul 2019, In : British journal of haematology. 186, 2, p. 358-360 3 p.

Research output: Contribution to journalLetter

Open Access
2 Scopus citations
2018

Blast-phase chronic myelomonocytic leukemia: more than just semantics

Patnaik, M. M., Tefferi, A. & Garcia-Manero, G., Sep 1 2018, In : Leukemia. 32, 9, p. 2093-2094 2 p.

Research output: Contribution to journalLetter

1 Scopus citations
2017
31 Scopus citations
2016

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis: A practical review

Farhadfar, N., Cerquozzi, S., Patnaik, M. M. & Tefferi, A., Jul 1 2016, In : Journal of Oncology Practice. 12, 7, p. 611-621 11 p.

Research output: Contribution to journalReview article

12 Scopus citations
2018

Polycythemia vera and essential thrombocythemia: Algorithmic approach

Vannucchi, A. M., Guglielmelli, P. & Tefferi, A., Mar 1 2018, In : Current Opinion in Hematology. 25, 2, p. 112-119 8 p.

Research output: Contribution to journalReview article

3 Scopus citations
2016

Myeloproliferative neoplasms: A decade of discoveries and treatment advances

Tefferi, A., Jan 1 2016, In : American Journal of Hematology. 91, 1, p. 50-58 9 p.

Research output: Contribution to journalArticle

66 Scopus citations
2018

Upfront low-dose ponatinib (15 mg/day) for multi-TKI resistant chronic myeloid leukemia

Tefferi, A., Oct 1 2018, In : Hematological Oncology. 36, 4, p. 718-720 3 p.

Research output: Contribution to journalLetter

4 Scopus citations
2019
9 Scopus citations
2016

Somatic JAK2 mutations and their tumor phenotypes

Tefferi, A., Aug 11 2016, In : Blood. 128, 6, p. 748-749 2 p.

Research output: Contribution to journalComment/debate

3 Scopus citations
2018

Polycythemia vera treatment algorithm 2018

Tefferi, A., Vannucchi, A. M. & Barbui, T., Jan 1 2018, In : Blood cancer journal. 8, 1, 3.

Research output: Contribution to journalArticle

16 Scopus citations

Myelofibrosis Treatment Algorithm 2018

Tefferi, A., Guglielmelli, P., Pardanani, A. D. & Vannucchi, A. M., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 72.

Research output: Contribution to journalArticle

8 Scopus citations
2016

Busulfan for the treatment of myeloproliferative neoplasms: the Mayo Clinic experience

Begna, K., Abdelatif, A., Schwager, S., Hanson, C., Pardanani, A. D. & Tefferi, A., May 27 2016, In : Blood Cancer Journal. 6, p. e427

Research output: Contribution to journalLetter

8 Scopus citations
2018

Smoldering mastocytosis: Survival comparisons with indolent and aggressive mastocytosis

Tefferi, A., Shah, S., Reichard, K. K., Hanson, C. A. & Pardanani, A. D., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

4 Scopus citations
2020

Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management

Szuber, N., Elliott, M. & Tefferi, A., Feb 1 2020, In : American journal of hematology. 95, 2, p. 212-224 13 p.

Research output: Contribution to journalArticle

2018

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion

Barbui, T., Thiele, J., Gisslinger, H., Kvasnicka, H. M., Vannucchi, A. M., Guglielmelli, P., Orazi, A. & Tefferi, A., Feb 9 2018, In : Blood cancer journal. 8, 2, 1 p.

Research output: Contribution to journalReview article

68 Scopus citations
2017

Downregulation of GATA1 drives impaired hematopoiesis in primary myelofibrosis

Gilles, L., Arslan, A. D., Marinaccio, C., Wen, Q. J., Arya, P., McNulty, M., Yang, Q., Zhao, J. C., Konstantinoff, K., Lasho, T., Pardanani, A. D., Stein, B., Plo, I., Sundaravel, S., Wickrema, A., Migliaccio, A., Gurbuxani, S., Vainchenker, W., Platanias, L. C., Tefferi, A. & 1 others, Crispino, J. D., Apr 3 2017, In : Journal of Clinical Investigation. 127, 4, p. 1316-1320 5 p.

Research output: Contribution to journalArticle

28 Scopus citations
2016

Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes

Sharma, P., Shinde, S. S., Damlaj, M., Hefazi Rorghabeh, M., Hashmi, S. K., Litzow, M. R., Hogan, W., Gangat, N., Elliott, M. A., Al-Kali, A., Tefferi, A. & Patnaik, M. M., Aug 10 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-10 10 p.

Research output: Contribution to journalArticle

10 Scopus citations

Acute leukemia in pregnancy: a single institution experience with 23 patients

Farhadfar, N., Cerquozzi, S., Hessenauer, M. R., Litzow, M. R., Hogan, W., Letendre, L., Patnaik, M. M., Tefferi, A. & Gangat, N., Aug 25 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-9 9 p.

Research output: Contribution to journalArticle

2 Scopus citations
2017

Therapy related-chronic myelomonocytic leukemia (CMML): Molecular, cytogenetic, and clinical distinctions from de novo CMML

Patnaik, M. M., Vallapureddy, R., Yalniz, F. F., Hanson, C. A., Ketterling, R. P., Lasho, T. L., Finke, C., Al-Kali, A., Gangat, N. & Tefferi, A., 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

16 Scopus citations

Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey

Begna, K., Al-Kali, A., Elliott, M., Foran, J. M., Gangat, N., Hogan, W., Hook, C., Leis, J., Litzow, M. R., Mesa, R., Palmer, J., Pardanani, A. D., Patnaik, M. M., Rivera, C. E., Sproat, L., Tibes, R., Wolanskyj-Spinner, A. & Tefferi, A., 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

1 Scopus citations
2020

Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients

Coltro, G., Mangaonkar, A. A., Lasho, T. L., Finke, C. M., Pophali, P., Carr, R., Gangat, N., Binder, M., Pardanani, A., Fernandez-Zapico, M., Robertson, K. D., Bosi, A., Droin, N., Vannucchi, A. M., Tefferi, A., Hunter, A., Padron, E., Solary, E. & Patnaik, M. M., May 1 2020, In : Leukemia. 34, 5, p. 1407-1421 15 p.

Research output: Contribution to journalArticle

1 Scopus citations
2018

Practice-relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm

Tefferi, A., Shah, S., Lasho, T. L., Patnaik, M. M., Reichard, K. K., Hanson, C. A., Ketterling, R. P. & Pardanani, A. D., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

2016

Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

Tefferi, A., Al-Kali, A., Begna, K. H., Patnaik, M. M., Lasho, T. L., Rizo, A., Wan, Y. & Hanson, C. A., Mar 11 2016, In : Blood cancer journal. 6, e405.

Research output: Contribution to journalLetter

14 Scopus citations
2018

MPL-mutated essential thrombocythemia: a morphologic reappraisal

Szuber, N., Hanson, C. A., Lasho, T. L., Finke, C., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Nov 20 2018, In : Blood Cancer Journal. 8, 12, 1 p.

Research output: Contribution to journalLetter

3 Scopus citations
2019

A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy

Gangat, N., Phelps, A., Lasho, T. L., Finke, C. M., Vallapureddy, R., Hanson, C. A., Ketterling, R. P., Patnaik, M. M., Pardanani, A. D. & Tefferi, A., Feb 1 2019, In : Blood Cancer Journal. 9, 2, 11.

Research output: Contribution to journalLetter

4 Scopus citations

Aurora kinase A inhibition provides clinical benefit, normalizes megakaryocytes, and reduces bone marrow fibrosis in patients with myelofibrosis: A phase I trial

Gangat, N., Marinaccio, C., Swords, R., Watts, J. M., Gurbuxani, S., Rademaker, A., Fought, A. J., Frankfurt, O., Altman, J. K., Wen, Q. J., Farnoud, N., Famulare, C. A., Patel, A., Tapia, R., Vallapureddy, R. R., Barath, S., Graf, A., Handlogten, A., Zblewski, D., Patnaik, M. M. & 14 others, Al-Kali, A., Dinh, Y. T., Prahl, K. E., Patel, S., Nobrega, J. C., Tejera, D., Thomassen, A., Gao, J., Ji, P., Rampal, R. K., Giles, F. J., Tefferi, A., Stein, B. & Crispino, J. D., Aug 15 2019, In : Clinical Cancer Research. 25, 16, p. 4898-4906 9 p.

Research output: Contribution to journalArticle

16 Scopus citations
2017

Prognostic impact of bone marrow fibrosis in polycythemia vera: Validation of the IWG-MRT study and additional observations

Barraco, D., Cerquozzi, S., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Mar 10 2017, In : Blood Cancer Journal. 7, 3, e538.

Research output: Contribution to journalArticle

12 Scopus citations
2018

GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis

Tefferi, A., Guglielmelli, P., Nicolosi, M., Mannelli, F., Mudireddy, M., Bartalucci, N., Finke, C. M., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Begna, K., Naseema Gangat, G., Pardanani, A. D. & Vannucchi, A. M., Mar 23 2018, (Accepted/In press) In : Leukemia. p. 1-12 12 p.

Research output: Contribution to journalArticle

41 Scopus citations

Pre-anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia

Ogden, J., Yui, J., Ali, W., Mudireddy, M., Al-Kali, A., Patnaik, M. M., Gangat, N., Elliott, M., Hogan, W., Hook, C., Wolanskyj-Spinner, A., Pardanani, A. D., Vilarraga, H. R., Litzow, M. R., Tefferi, A. & Begna, K., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

2019

World Health Organization class-independent risk categorization in mastocytosis

Pardanani, A. D., Lasho, T. L., Reichard, K. K., Hanson, C. A. & Tefferi, A., Mar 1 2019, In : Blood cancer journal. 9, 3, 29.

Research output: Contribution to journalLetter

Open Access
1 Scopus citations
2018

The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes

Penna, D., Nicolosi, M., Vallapureddy, R. R., Szuber, N., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N. & Tefferi, A., Jan 1 2018, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

1 Scopus citations

EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental

Patnaik, M. M., Vallapureddy, R., Lasho, T. L., Hoversten, K. P., Finke, C. M., Ketterling, R., Hanson, C., Gangat, N. & Tefferi, A., Jan 1 2018, In : Blood Cancer Journal. 8, 1, 12.

Research output: Contribution to journalLetter

12 Scopus citations
2016

Prognostic interaction between ASXL1 and TET2 mutations in chronic myelomonocytic leukemia

Patnaik, M. M., Lasho, T. L., Vijayvargiya, P., Finke, C. M., Hanson, C. A., Ketterling, R. P., Gangat, N. & Tefferi, A., 2016, In : Blood Cancer Journal. 6, 1, e385.

Research output: Contribution to journalArticle

57 Scopus citations
2017

Screening for ASXL1 and SRSF2 mutations is imperative for treatment decision-making in otherwise low or intermediate-1 risk patients with myelofibrosis

Tefferi, A., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Gangat, N. & Pardanani, A. D., Jan 1 2017, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

6 Scopus citations
2016

MPL mutations and palpable splenomegaly are independent risk factors for fibrotic progression in essential thrombocythemia

Haider, M., Elala, Y. C., Gangat, N., Hanson, C. A. & Tefferi, A., Oct 21 2016, In : Blood Cancer Journal. 6, 10, e487.

Research output: Contribution to journalLetter

13 Scopus citations
2018

Mayo alliance prognostic system for mastocytosis: Clinical and hybrid clinical-molecular models

Pardanani, A., Shah, S., Mannelli, F., Elala, Y. C., Guglielmelli, P., Lasho, T. L., Patnaik, M. M., Gangat, N., Ketterling, R. P., Reichard, K. K., Hanson, C. A., Vannucchi, A. M. & Tefferi, A., Nov 13 2018, In : Blood Advances. 2, 21, p. 2964-2972 9 p.

Research output: Contribution to journalArticle

Open Access
11 Scopus citations
2020

Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera

Tefferi, A., Guglielmelli, P., Lasho, T. L., Coltro, G., Finke, C. M., Loscocco, G. G., Sordi, B., Szuber, N., Rotunno, G., Pacilli, A., Hanson, C. A., Ketterling, R. P., Pardanani, A., Gangat, N. & Vannucchi, A. M., Apr 1 2020, In : British journal of haematology. 189, 2, p. 291-302 12 p.

Research output: Contribution to journalArticle

2019

Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients

Coston, T., Pophali, P., Vallapureddy, R., Lasho, T. L., Finke, C. M., Ketterling, R. P., Carr, R., Binder, M., Mangaonkar, A. A., Gangat, N., Al-Kali, A., Litzow, M. R., Zblewski, D., Pardanani, A. D., Tefferi, A. & Patnaik, M. M., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalArticle

9 Scopus citations

Cytogenetic clonal evolution in myeloproliferative neoplasms: contexts and prognostic impact among 648 patients with serial bone marrow biopsies

Tefferi, A., Nicolosi, M., Penna, D., Vallapureddy, R., Hanson, C. A., Pardanani, A. D., Gangat, N. & Ketterling, R. P., Jan 1 2019, In : Leukemia.

Research output: Contribution to journalLetter

2018

Sex and degree of severity influence the prognostic impact of anemia in primary myelofibrosis: analysis based on 1109 consecutive patients

Nicolosi, M., Mudireddy, M., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Gangat, N., Pardanani, A. D. & Tefferi, A., Jan 30 2018, (Accepted/In press) In : Leukemia. p. 1-5 5 p.

Research output: Contribution to journalArticle

9 Scopus citations

Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis

Tefferi, A., Lasho, T. L., Finke, C., Gangat, N., Hanson, C. A., Ketterling, R. P. & Pardanani, A. D., Mar 1 2018, In : Leukemia. 32, 3, p. 837-839 3 p.

Research output: Contribution to journalLetter

10 Scopus citations
2017

The prognostic relevance of serum lactate dehydrogenase and mild bone marrow reticulin fibrosis in essential thrombocythemia

Mudireddy, M., Barraco, D., Hanson, C. A., Pardanani, A. D., Gangat, N. & Tefferi, A., 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

9 Scopus citations

Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients

Tefferi, A., Nicolosi, M., Mudireddy, M., Szuber, N., Finke, C. M., Lasho, T. L., Hanson, C. A., Ketterling, R. P., Pardanani, A. D., Gangat, N., Mannarelli, C., Fanelli, T., Guglielmelli, P. & Vannucchi, A. M., Jan 1 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

28 Scopus citations
2016

Pruritus in primary myelofibrosis: management options in the era of JAK inhibitors

Vaa, B. E., Tefferi, A., Gangat, N., Pardanani, A. D., Lasho, T. L., Finke, C. M. & Wolanskyj, A. P., Apr 23 2016, (Accepted/In press) In : Annals of Hematology. p. 1-5 5 p.

Research output: Contribution to journalArticle

6 Scopus citations
2018

Validation of the WHO-defined 20% circulating blasts threshold for diagnosis of leukemic transformation in primary myelofibrosis

Mudireddy, M., Gangat, N., Hanson, C. A., Ketterling, R. P., Pardanani, A. D. & Tefferi, A., Jun 1 2018, In : Blood Cancer Journal. 8, 6

Research output: Contribution to journalLetter

3 Scopus citations